DNA methylation profiling in cancer

Yutaka Kondo1, Jean-Pierre J Issa

  • 1Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan. ykondo@aichi-cc.jp

Insights

Aberrant DNA methylation patterns are hallmarks of cancer, often silencing tumor-suppressor genes. Understanding these epigenetic signatures through genome-wide DNA methylation profiling is crucial for cancer diagnostics and therapy.

Area of Science:

  • Genomics
  • Epigenetics
  • Oncology

Background:

  • Aberrant DNA methylation is prevalent in most cancers, contributing to malignant transformation by silencing tumor-suppressor genes.
  • Understanding tumor-specific DNA methylation signatures is vital for improved diagnostics and therapeutic strategies.

Purpose of the Study:

  • To review current key technologies for assessing genome-wide DNA methylation.
  • To discuss the implications of DNA methylation profiling in human cancers.

Main Methods:

  • Review of current high-throughput technologies for genome-wide DNA methylation analysis.
  • Discussion of epigenetic profiling techniques.

Main Results:

  • High-throughput technologies offer potent tools for epigenetic profiling.
  • DNA methylation profiling provides insights into tumor behavior.

Conclusions:

  • Efficient epigenetic profiling is essential, given the clinical use and trials of epigenetic therapies.
  • DNA methylation profiling holds significant potential for cancer diagnostics and treatment.